Effects of resveratrol analogs on steroidogenesis and mitochondrial function in rat Leydig cells in vitro

被引:44
作者
Svechnikov, Konstantin [1 ]
Spatafora, Carmela [2 ]
Svechnikova, Irina [1 ]
Tringali, Corrado [2 ]
Sodder, Olle [1 ]
机构
[1] Karolinska Inst & Univ Hosp, Dept Woman & Child Hlth, Pediat Endocrinol Unit, SE-17176 Stockholm, Sweden
[2] Univ Catania, Dipartimento Sci Chim, I-95125 Catania, Italy
基金
瑞典研究理事会;
关键词
Leydig cells; resveratrol analogs; steroidogenesis; ESTROGEN-RECEPTOR-ALPHA; FETAL TESTIS; EXPRESSION; PROTEIN; BETA; INTERLEUKIN-1-ALPHA; INHIBITION; INDUCTION; STILBENES; ISOFORMS;
D O I
10.1002/jat.1456
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Resveratrol and its analogs are considered to be a promising drug candidate for treatment of cancer and different age-associated diseases. In the present study we have investigated the effects of resveratrol and its synthetic analogs on steroidogenesis and mitochondrial function in primary cultures of rat Leydig cells. Our findings indicate that resveratrol and its analogs structure-dependently attenuated hCG-activated steroidogenesis in Leydig cells through suppression of the expression of steroidogenic acute regulatory protein and cytochrome P450c17. 3,5-Diacetyl resveratrol was observed to modulate mitochondrial function in Leydig cells, suppressing polarization of inner mitochondrial membrane, and 3,4,4'-trimethoxystilbene stimulated the overall activity of intracellular reductases involved in the reduction of WST-1 to formazan. Thus, the inhibitory actions of resveratrol analogs on steroidogenesis in Leydig cells indicate novel mechanisms of action of these compounds, which may be of potential therapeutic interest, where suppression of androgen action is needed. Copyright (C) 2009 John Wiley & Sons, Ltd.
引用
收藏
页码:673 / 680
页数:8
相关论文
共 26 条
[1]   Estrogen receptor-α gene deficiency enhances androgen biosynthesis in the mouse Leydig cell [J].
Akingbemi, BT ;
Ge, RS ;
Rosenfeld, CS ;
Newton, LG ;
Hardy, DO ;
Catterall, JF ;
Lubahn, DB ;
Korach, KS ;
Hardy, MP .
ENDOCRINOLOGY, 2003, 144 (01) :84-93
[2]   Energized, polarized, and actively respiring mitochondria are required for acute Leydig cell steroidogenesis [J].
Allen, John A. ;
Shankara, Tristan ;
Janus, Paul ;
Buck, Steve ;
Diemer, Thorsten ;
Hales, Karen Held ;
Hales, Dale B. .
ENDOCRINOLOGY, 2006, 147 (08) :3924-3935
[3]   Therapeutic potential of resveratrol:: the in vivo evidence [J].
Baur, Joseph A. ;
Sinclair, David A. .
NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (06) :493-506
[4]   Resveratrol acts as a mixed agonist/antagonist for estrogen receptors α and β [J].
Bowers, JL ;
Tyulmenkov, VV ;
Jernigan, SC ;
Klinge, CM .
ENDOCRINOLOGY, 2000, 141 (10) :3657-3667
[5]   Chemo-enzymatic synthesis and cell-growth inhibition activity of resveratrol analogues [J].
Cardile, V ;
Lombardo, L ;
Spatafora, C ;
Tringali, C .
BIOORGANIC CHEMISTRY, 2005, 33 (01) :22-33
[6]   Estrogen receptor α is a major contributor to estrogen-mediated fetal testis dysgenesis and cryptorchidism [J].
Cederroth, Christopher R. ;
Schaad, Olivier ;
Descombes, Patrick ;
Chambon, Pierre ;
Vassalli, Jean-Dominique ;
Nef, Serge .
ENDOCRINOLOGY, 2007, 148 (11) :5507-5519
[7]  
CLARK BJ, 1994, J BIOL CHEM, V269, P28314
[8]   Differential expression of two estrogen receptor β isoforms in the human fetal testis during the second trimester of pregnancy [J].
Gaskell, TL ;
Robinson, LLL ;
Groome, NP ;
Anderson, RA ;
Saunders, PTK .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (01) :424-432
[9]   The effects of oestrogen receptors α and β on testicular cell number and steroidogenesis in mice [J].
Gould, M. L. ;
Hurst, P. R. ;
Nicholson, H. D. .
REPRODUCTION, 2007, 134 (02) :271-279
[10]   Substituted trans-stilbenes, including analogues of the natural product resveratrol, inhibit the human tumor necrosis factor alpha-induced activation of transcription factor nuclear factor KappaB [J].
Heynekamp, Justin J. ;
Weber, Waylon M. ;
Hunsaker, Lucy A. ;
Gonzales, Amanda M. ;
Orlando, Robert A. ;
Deck, Lorraine M. ;
Jagt, David L. Vander .
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (24) :7182-7189